ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Cuadrado, Eloy ^a   Booiman, Thijs ^a,b   Van Hamme, John L ^a,b   Jansen, Machiel H ^a   Van Dort, Karel A ^a,b   Vanderver, Adeline ^c   Rice, Gillian I ^d   Crow, Yanick J ^d,e   Kootstra, Neeltje A ^a,b   Kuijpers, Taco W ^a,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE ACTING ON RNA 1; INTERFERON; UNCLASSIFIED DRUG; VIRUS ENZYME; ADAR1 PROTEIN, HUMAN; ADENOSINE DEAMINASE; MESSENGER RNA; RNA BINDING PROTEIN; VIRUS RNA;

ADOLESCENT; AICARDI GOUTIERES SYNDROME; ARTICLE; BLOOD LEVEL; CASE REPORT; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE FUNCTION; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRESCHOOL CHILD; PROTEIN DETERMINATION; PROTEIN FUNCTION; SCHOOL CHILD; VIRUS REPLICATION; CELL CULTURE; FLOW CYTOMETRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JURKAT CELL LINE; METABOLISM; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; WESTERN BLOTTING;

ADENOSINE DEAMINASE; ADOLESCENT; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; RNA-BINDING PROTEINS; VIRUS REPLICATION;

EID: 84955500564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143613     Document Type: Article

References (35)

1. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol. 2010; 11: 1005-1013. doi: 10.1038/ni.1941 PMID: 20871604
2. Baldauf H- M, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nature Medicine. 2012; 18: 1682-1689. doi: 10.1038/nm.2964 PMID: 22972397
3. Berger A, Sommer AFR, Zwarg J, Hamdorf M, Welzel K, Esly N, et al. SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection. PLoS Pathog. 2011; 7.
4. Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim S-Y, et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med. 2014
5. Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet. 2006; 38: 917-920. doi: 10.1038/ng1845 PMID: 16845398
6. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009; 41: 829-832. doi: 10.1038/ng.373 PMID: 19525956
7. Lebon P, Badoual J, Ponsot G, Goutières F, Hémeury-Cukier F, Aicardi J. Intrathecal synthesis of interferon- alpha in infants with progressive familial encephalopathy. J Neurol Sci. 1988; 84: 201-208. PMID: 2837539
8. Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nature Genetics. 2006; 38: 910-916. doi: 10.1038/ng1842 PMID: 16845400
9. Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GMA, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 2014; 46: 503-509. doi: 10.1038/ng.2933 PMID: 24686847
10. Oda H, Nakagawa K, Abe J, Awaya T, Funabiki M, Hijikata A, et al. Aicardi-Goutières Syndrome Is Caused by IFIH1 Mutations. Am J Hum Genet. 2014; 95: 121-125. doi: 10.1016/j.ajhg.2014.06.007 PMID: 24995871
11. Rice GI, Kasher PR, Forte GMA, Mannion NM, Greenwood SM, Szynkiewicz M, et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet. 2012; 44: 1243-1248. doi: 10.1038/ng.2414 PMID: 23001123
12. Yang Y-G, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell. 2007; 131: 873-886. doi: 10.1016/j.cell.2007.10.017 PMID: 18045533
13. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008; 134: 587-598. doi: 10.1016/j.cell.2008.06.032 PMID: 18724932
14. Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M Jr, Barber GN, et al. Autoimmunity Initiates in Nonhematopoietic Cells and Progresses via Lymphocytes in an Interferon-Dependent Autoimmune Disease. Immunity. 2012; 36: 120-131. doi: 10.1016/j.immuni.2011.11.018 PMID: 22284419
15. Tang Y-D, Na L, Fu L-H, Yang F, Zhu C-H, Tang L, et al. Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. Virology. 2015; 476: 364-371. doi: 10. 1016/j.virol.2014.12.038 PMID: 25589239
16. Gélinas J-F, Clerzius G, Shaw E, Gatignol A. Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase. J Virol. 2011; 85: 8460-8466. doi: 10.1128/ JVI.00240-11 PMID: 21490091
17. Polson AG, Ley HL 3rd, Bass BL, Casey JL. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol Cell Biol. 1998; 18: 1919-1926. PMID: 9528763
18. Sato S, Wong SK, Lazinski DW. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J Virol. 2001; 75: 8547-8555. PMID: 11507200
19. Taylor DR, Puig M, Darnell MER, Mihalik K, Feinstone SM. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol. 2005; 79: 6291-6298. doi: 10.1128/ JVI.79.10.6291-6298.2005 PMID: 15858013
20. Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology. 2011; 411: 180-193. doi: 10.1016/j.virol.2010.12.004 PMID: 21211811
21. Phuphuakrat A, Kraiwong R, Boonarkart C, Lauhakirti D, Lee T-H, Auewarakul P. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J Virol. 2008; 82: 10864-10872. doi: 10.1128/JVI.00238-08 PMID: 18753201
22. Doria M, Neri F, Gallo A, Farace MG, Michienzi A. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 2009; 37: 5848-5858. doi: 10.1093/ nar/gkp604 PMID: 19651874
23. Clerzius G, Gélinas J-F, Daher A, Bonnet M, Meurs EF, Gatignol A. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J Virol. 2009; 83: 10119-10128. doi: 10.1128/JVI.02457-08 PMID: 19605474
24. Biswas N, Wang T, Ding M, Tumne A, Chen Y, Wang Q, et al. ADAR1 is a novel multi targeted anti- HIV-1 cellular protein. Virology. 2012; 422: 265-277. doi: 10.1016/j.virol.2011.10.024 PMID: 22104209
25. Arrighi J-F, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol. 2004; 78: 10848-10855. doi: 10.1128/JVI.78.20.10848-10855.2004 PMID: 15452205
26. Arrighi J-F, Pion M, Garcia E, Escola J-M, van Kooyk Y, Geijtenbeek TB, et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med. 2004; 200: 1279-1288. doi: 10.1084/jem.20041356 PMID: 15545354
27. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998; 72: 8463-8471. PMID: 9765382
28. Tersmette M, Winkel IN, Groenink M, Gruters RA, Spence RP, Saman E, et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag. Virology. 1989; 171: 149-155. PMID: 2472701
29. Der SD, Zhou A, Williams BRG, Silverman RH. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. PNAS. 1998; 95: 15623-15628. doi: 10.1073/pnas.95.26. 15623 PMID: 9861020
30. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272: 1955-1958. PMID: 8658171
31. Clerzius G, Shaw E, Daher A, Burugu S, Gélinas J-F, Ear T, et al. The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication. Retrovirology. 2013; 10: 96. doi: 10.1186/1742-4690-10-96 PMID: 24020926
32. Nie Y, Hammond GL, Yang J-H. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J Virol. 2007; 81: 917-923. doi: 10.1128/JVI.01527-06 PMID: 17079286
33. Toth AM, Li Z, Cattaneo R, Samuel CE. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem. 2009; 284: 29350-29356. doi: 10.1074/jbc.M109.045146 PMID: 19710021
34. Okonski KM, Samuel CE. Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1. J Virol. 2013; 87: 756-766. doi: 10. 1128/JVI.02270-12 PMID: 23115276
35. Cachat A, Alais S, Chevalier SA, Journo C, Fusil F, Dutartre H, et al. ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity. Retrovirology. 2014; 11: 93. doi: 10.1186/s12977- 014-0093-9 PMID: 25389016